# Thermo Fisher Scientific Inc.: Form 10-Q for the period ended Jun 27, 2020

- Company: [Thermo Fisher Scientific Inc.](/companies/tmo.md) (CIK 97745)
- Form: 10-Q
- Filed: 2020-07-31
- Accepted by EDGAR: Jul 31, 2020, 10:33 ET
- Period: 2020-06-27
- Accession: 0000097745-20-000038
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/97745/000009774520000038/tmo-20200627.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/97745/000009774520000038/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-06-27.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2020-03-29 to 2020-06-27 | $6.92bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months, 2020-01-01 to 2020-06-27 | $13.15bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Research and development | 3 months, 2020-03-29 to 2020-06-27 | $264.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2020-01-01 to 2020-06-27 | $509.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2020-03-29 to 2020-06-27 | $1.71bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2020-01-01 to 2020-06-27 | $3.26bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2020-03-29 to 2020-06-27 | $1.39bn | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2020-01-01 to 2020-06-27 | $2.30bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2020-03-29 to 2020-06-27 | $137.0m | us-gaap:InterestExpense |
| Interest expense | 6 months, 2020-01-01 to 2020-06-27 | $263.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2020-03-29 to 2020-06-27 | $97.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2020-01-01 to 2020-06-27 | $137.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2020-03-29 to 2020-06-27 | $1.16bn | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Net income | 6 months, 2020-01-01 to 2020-06-27 | $1.94bn | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Diluted EPS | 3 months, 2020-03-29 to 2020-06-27 | $2.90 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2020-01-01 to 2020-06-27 | $4.87 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2020-03-29 to 2020-06-27 | $2.92 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2020-01-01 to 2020-06-27 | $4.91 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2020-03-29 to 2020-06-27 | 398,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2020-01-01 to 2020-06-27 | 399,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2020-01-01 to 2020-06-27 | $2.24bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2020-01-01 to 2020-06-27 | $522.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months, 2020-01-01 to 2020-06-27 | $163.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months, 2020-01-01 to 2020-06-27 | $1.50bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2020-06-27 | $5.82bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-06-27 | $15.78bn | us-gaap:AssetsCurrent |
| Total assets | at 2020-06-27 | $61.59bn | us-gaap:Assets |
| Current liabilities | at 2020-06-27 | $6.01bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2020-06-27 | $20.64bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2020-06-27 | $675.0m | us-gaap:DebtCurrent |
| Shareholders' equity | at 2020-06-27 | $29.88bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2020-06-27 | 395,589,400 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/97745/000009774520000038/tmo-20200627.htm

Filed Jul 31, 2020.
Source: SEC EDGAR, the filing index for accession 0000097745-20-000038. Last ingested by Listed: Nov 14, 2026, 12:05 ET. No prices; not investment advice.
